Technology | January 13, 2015

Ambry Genetics Launches Tiered Approach to Cardiovascular Genetic Testing

Testing panels for cardiomyopathies and arrhythmias offer enhanced analysis, faster turnaround time

Ambry Genetics, genetic testing, CardioNext, HCM, Rhythm

January 13, 2015 — Ambry Genetics announces the launch of cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an intuitive, tiered approach to testing for hypertrophic cardiomyopathy, long QT syndrome and Brugada syndrome. Sudden death may be the first and only symptom of some of these disorders. Genetic testing can be life-saving and directly impacts medical care when confirming a diagnosis and/or identifying at-risk individuals. These new panels feature next-generation sequencing, deletion/duplication analysis, comprehensive coverage and turnaround times as low as 3-4 weeks.

As with all of Ambry’s tests, cardiovascular genetic test reports will provide in-depth interpretation. An extensive literature review and assessment of all databases are performed when interpreting a gene mutation or variant of unknown significance (VUS).

The new testing includes an 84-gene comprehensive cardiovascular genetics panel (CardioNext), hypertrophic cardiomyopathy panels (HCMFirst and HCMNext), inherited arrhythmia panels (RhythmFirst and RhythmNext) and a comprehensive inherited cardiomyopathy panel (CMNext). Multi-gene panels targeted to specific inherited cardiomyopathies and arrhythmias are also available.

For more information: www.ambrygen.com

Related Content

Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
Subscribe Now